Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 29.45B | 29.61B | 32.16B | 33.73B | 33.25B |
Gross Profit | 15.01B | 15.59B | 17.05B | 18.21B | 18.06B |
EBITDA | 1.01B | -125.00M | 1.46B | 1.88B | 1.92B |
Net Income | 136.00M | -858.00M | 671.00M | 1.65B | 1.28B |
Balance Sheet | |||||
Total Assets | 28.89B | 29.06B | 31.54B | 31.93B | 35.72B |
Cash, Cash Equivalents and Short-Term Investments | 9.51B | 9.06B | 12.10B | 13.51B | 17.91B |
Total Debt | 9.00M | 15.00M | 20.00M | 26.00M | 3.00B |
Total Liabilities | 9.62B | 10.12B | 11.66B | 12.38B | 17.66B |
Stockholders Equity | 19.27B | 18.94B | 19.88B | 19.55B | 18.06B |
Cash Flow | |||||
Free Cash Flow | 426.00M | -1.88B | -917.00M | -1.35B | 1.06B |
Operating Cash Flow | 691.00M | -877.00M | 191.00M | 1.84B | 2.54B |
Investing Cash Flow | -1.90B | -1.42B | -641.00M | -3.41B | 676.00M |
Financing Cash Flow | -112.00M | -112.00M | -112.00M | -3.11B | -449.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | ¥40.37B | 19.77 | 0.27% | 24.11% | 22.03% | ||
65 Neutral | ¥5.63B | 59.27 | ― | 36.06% | -60.50% | ||
60 Neutral | €8.55B | 7.71 | -14.37% | 4.76% | 1.65% | -51.94% | |
58 Neutral | ¥5.52B | 37.08 | 1.82% | 0.86% | ― | ||
51 Neutral | ¥9.27B | ― | ― | -8.69% | 41.07% | ||
46 Neutral | ¥9.49B | ― | 4.81% | 6.19% | 21.85% | ||
40 Underperform | ¥11.35B | ― | ― | -4.20% | -14.64% |